Co-Authors
This is a "connection" page, showing publications co-authored by PAVEL SUMAZIN and MICHELE REDELL.
Connection Strength
0.335
-
Characterization of Chemoresistant Cell Populations Improves Risk Stratification and Therapy Prediction in Pediatric AML. bioRxiv. 2025 Oct 20.
Score: 0.239
-
Identification of single-cell blasts in pediatric acute myeloid leukemia using an autoencoder. Life Sci Alliance. 2024 11; 7(11).
Score: 0.055
-
Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation. Blood Adv. 2019 12 23; 3(24):4215-4227.
Score: 0.040